Comparison of effective I‐131 half‐life between thyroid hormone withdrawal and recombinant human thyroid‐stimulating hormone for thyroid cancer: A retrospective study

Publisher： John Wiley & Sons Inc

E-ISSN： 1754-9485|59|2|248-254

ISSN： 1754-9477

Source： JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, Vol.59, Iss.2, 2015-04, pp. : 248-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Authors’ Reply: Statins and thyroid‐stimulating hormone

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 5, 2015-11 ,pp. : 747-748

John Wiley & Sons Inc

Access to resources Recommend Favorite

Statins and thyroid‐stimulating hormone concentrations in patients with type 2 diabetes

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 5, 2015-11 ,pp. : 746-747

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum Thyroid-Stimulating Hormone as a Predictor of Cognitive Impairment in an Elderly Cohort

By  

Gerontology, Vol. 58, Iss. 1, 2011-03 ,pp. : 41-49

Karger

Access to resources Recommend Favorite

Thyroid‐stimulating hormone acutely increases levels of circulating pro‐coagulant microparticles

By  

CLINICAL ENDOCRINOLOGY, Vol. 83, Iss. 2, 2015-08 ,pp. : 285-287

John Wiley & Sons Inc

Access to resources Recommend Favorite

Using record linkage to investigate perinatal factors and neonatal thyroid‐stimulating hormone

By  

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 6, 2015-06 ,pp. : 620-625

John Wiley & Sons Inc

Access to resources Recommend Favorite